Endometrial cancer: Can nodal status be predicted with curettage?

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 594-600

  Mariani, Andrea ^a   Sebo, Thomas J ^a   Katzmann, Jerry A ^a   Roche, Patrick C ^a   Keeney, Gary L ^a   Lesnick, Timothy G ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

bcl 2; Dilatation and curettage; Endometrial cancer; Lymphadenectomy; Lymphatic metastases; Nonendometrioid histology; p53

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; CANCER PATIENT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CURETTAGE; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PHENOTYPE; PLOIDY; POPULATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

EID: 13844280397     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.030     Document Type: Conference Paper

References (36)

1. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, and E. Ward Cancer Statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
2. W.T. Creasman, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, and A.P. Heintz Carcinoma of the corpus uteri J. Epidemiol. Biostat. 6 2001 47 86
3. K.C. Podratz, A. Mariani, and M.J. Webb Staging and therapeutic value of lymphadenectomy in endometrial cancer (editorial) Gynecol. Oncol. 70 1998 163 164 10.1006/gyno.1998.5150
4. A. Mariani, M.J. Webb, L. Galli, and K.C. Podratz Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer Gynecol. Oncol. 76 2000 348 356 10.1006/gyno.1999.5688
5. L.C. Kilgore, E.E. Partridge, R.D. Alvarez, J.M. Austin, H.M. Shingleton, and F. Noojin III Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling Gynecol. Oncol. 56 1995 29 33 10.1006/gyno.1995.1005
6. J.W. Orr Jr., P.Y. Roland, D. Leichter, and P.F. Orr Endometrial cancer: is surgical staging necessary? Curr. Opin. Oncol. 13 2001 408 412
7. L. McGowan, L.P. Lesher, H.J. Norris, and M. Barnett Misstaging of ovarian cancer Obstet. Gynecol. 65 1985 568 572
8. K. Munstedt, R. von Georgi, B. Misselwitz, M. Zygmunt, R. Stillger, and W. Kunzel Centralizing surgery for gynecologic oncology: a strategy assuring better quality treatment? Gynecol. Oncol. 89 2003 4 8
9. E.E. Partridge, J.M. Jessup, E.S. Donaldson, P.T. Taylor, M. Randall, and P. Braley 1996 patient care evaluation study (PCE) of cancer of the corpus uteri, National Cancer Database (NCDB), American College of Surgery (abstract) Gynecol. Oncol. 72 1999 445 10.1006/gyno.1998.5330
10. A. Mariani, M.J. Webb, G.L. Keeney, G. Aletti, and K.C. Podratz Predictors of lymphatic failure in endometrial cancer Gynecol. Oncol. 84 2002 437 442 10.1006/gyno.2001.6550
11. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041 [Suppl]
12. M. Ikeda, Y. Watanabe, T. Nanjoh, and K. Noda Evaluation of DNA ploidy in endometrial cancer Gynecol. Oncol. 50 1993 25 29 10.1006/gyno.1993.1158
13. N. Sakuragi, T. Ohkouchi, H. Hareyama, K. Ikeda, H. Watari, and T. Fujimoto Bcl-2 expression and prognosis of patients with endometrial carcinoma Int. J. Cancer 79 1998 153 158
14. A. Mariani, T.J. Sebo, J.A. Katzmann, G.L. Keeney, P.C. Roche, and T.G. Lesnick Pretreatment assessment of prognostic indicators in endometrial cancer Am. J. Obstet. Gynecol. 182 2000 1535 1544
15. R.L. Prentice A case-cohort design for epidemiologic cohort studies and disease prevention trials Biometrika 73 1986 1 11
16. R.E. Scully, T.A. Bonfiglio, R.J. Kurman, S.G. Silverberg, and E.J. Wilkinson Histological typing of female genital tract tumours World Health Organization, International Histological Classification of Tumours 2nd ed. 1994 Springer-Verlag Berlin Heidelberg 13 18
17. S.M. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 29 1981 577 580
18. G. Olt, J. Soper, S. Ramakrishnan, F. Xu, A. Berchuck, and D. Clarke-Pearson Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer Am. J. Obstet. Gynecol. 174 1996 1316 1319
19. D.W. Hedley, M.L. Friedlander, I.W. Taylor, C.A. Rugg, and E.A. Musgrove Method for analysis of cellular DNA content of paraffin-imbedded pathological material using flow cytometry J. Histochem. Cytochem. 31 1983 1333 1335
20. L.L. Vindelov, I.J. Christensen, and N.I. Nissen A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis Cytometry 3 1983 323 327
21. N.J. Gonchoroff, J.J. Ryan, T.K. Kimlinger, T.E. Witzig, P.R. Greipp, and J.S. Meyer Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometry Cytometry 11 1990 642 646
22. H. Baisch, W. Gohde, and W.A. Linden Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle Radiat. Environ. Biophys. 12 1975 31 39
23. K.C. Podratz, T.O. Wilson, T.A. Gaffey, S.S. Cha, and J.A. Katzmann Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients Am. J. Obstet. Gynecol. 168 1993 1206 1213
24. A. Agresti Categorical data analysis 1990 Wiley New York 508 540
25. B.W. Corn, C.J. Dunton, J.A. Carlson, Y. Xie, and R.K. Valicenti National trends in the surgical staging of corpus cancer: a pattern-of-practice survey Obstet. Gynecol. 90 1997 628 631
26. W.F. Cheng, C.A. Chen, C.N. Lee, T.M. Chen, K.T. Huang, and C.Y. Hsieh Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients Gynecol. Oncol. 71 1998 424 427 10.1006/gyno.1998. 5164
27. T. Toki, K. Oka, K. Nakayama, O. Oguchi, and S. Fujii A comparative study of pre-operative procedures to assess cervical invasion by endometrial carcinoma Br. J. Obstet. Gynaecol. 105 1998 512 516
28. G. Scambia, A. Gadducci, P.B. Panici, E. Foti, M. Ferdeghini, and G. Ferrandina Combined us of CA 125 and CA 15-3 in patients with endometrial carcinoma Gynecol. Oncol. 54 1994 292 297 10.1006/gyno.1994.1213
29. K. Fukuda, M. Mori, M. Uchiyama, K. Iwai, T. Iwasaka, and H. Sugimori Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance Gynecol. Oncol. 72 1999 273 277 10.1006/gyno.1998. 5244
30. W. Creasman, F. Odicino, and P. Maisonneuve Carcinoma of the corpus uteri: annual report on the results of treatment in gynecology J. Epidemiol. Biostat. 3 1998 35 61
31. L. Nedergaard, M. Jacobsen, and J.E. Andersen Interobserver agreement for tumor type, grade of differentiation and stage in endometrial carcinomas APMIS 103 1995 511 518
32. T.J. Sebo Digital image analysis Mayo Clin. Proc. 70 1995 81 82
33. J.P. Geisler, M.C. Wiemann, Z. Zhou, G.A. Miller, and H.E. Geisler Proliferation index determined by MIB-1 and recurrence in endometrial cancer Gynecol. Oncol. 61 1996 373 377 10.1006/gyno.1996.0159
34. H.B. Salvesen, O.E. Iversen, and L.A. Akslen Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas Clin. Cancer Res. 4 1998 2779 2785
35. D.J. Hetzel, T.O. Wilson, G.L. Keeney, P.C. Roche, S.S. Cha, and K.C. Podratz HER-2/neu expression: a major prognostic factor in endometrial cancer Gynecol. Oncol. 47 1992 179 185
36. A. Mariani, T.J. Sebo, M.J. Webb, D. Riehle, J.A. Katzmann, and G.L. Keeney Molecular and histopathologic predictors of distant failure in endometrial cancer Cancer Detect. Prev. 27 2003 434 441